The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 5.00 (0.29%)
Spread: 0.50 (0.029%)
Open: 1,733.00
High: 1,739.50
Low: 1,724.50
Prev. Close: 1,728.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London open: Fed comments provide support ahead of BoE, ECB

Thu, 07th Mar 2013 08:43

The FTSE 100 held on to recent gains on Thursday morning ahead of central-bank policy decisions in the UK and Europe, as comments from the Federal Reserve provided some support.According to the Fed's Beige Book released last night, the US economy expanded at a "modest to moderate pace" at the start of 2013 due to strong car sales, hiring gains and a recovery in the housing sector.The UK benchmark index surged to levels not seen since late 2007 earlier this week a better-than-expected reading of US services activity and a pledge by China to hit its growth targets this year boosted markets.It appears that markets were pausing for breath today ahead of policy decisions from the Bank of England and European Central Bank expected after midday. Speculation has increased over the last month about changes to policy from both sides so investors are likely to sit on their hands and refrain from taking risk until someone makes a move.Overnight, the Bank of Japan voted to keep interest rates and its asset purchase programme unchanged, a decision that was widely expected given the Bank's recent aggressive easing.FTSE 100: Aviva plummets after 'rebasing' diviInsurance giant Aviva was forced to slash to dividend after swinging into the red in 2012, after taking a 3.3bn-pound write-down on a disposal in the US. Aviva also said that its overall situation does not warrant bonuses for executive directors for 2012 or pay rises for 2013. Shares dropped sharply early on.Heading the other way was temporary power and temperature control provider Aggreko after posting a strong performance with trading profit up 13% last year.Insurance provider Standard Life gained after unveiling a windfall dividend worth £302m after delivering substantial growth in profits in 2012 underpinned by strong performance in the UK.British asset management firm Schroders was higher after saying that assets under management (AuM) reached record levels in spite of choppy markets and falling profits.Pharma giant GlaxoSmithKline rose after announcing positive data from a drug study through ViiV Healthcare, a global specialist HIV company set up by GSK in 2009.FTSE 250: National Express dropsTransport group National Express was a heavy faller after reports yesterday said that US investor Elliot Advisors plans to sell over 50m worth of shares, equal to a 9.9% stake.Engineering firm Spirax-Sarco was in demand after proposing a special dividend of 100p per share in addition to an 8.0% rise in the full-year payout, after a 2.0% rise in revenue in 2012.FTSE 100 - RisersAggreko (AGK) 1,932.00p +9.90%IMI (IMI) 1,328.00p +5.23%Admiral Group (ADM) 1,362.00p +2.10%Standard Life (SL.) 380.30p +1.63%Unilever (ULVR) 2,721.00p +1.45%Barclays (BARC) 306.50p +1.44%Reckitt Benckiser Group (RB.) 4,568.00p +1.15%Antofagasta (ANTO) 1,075.00p +1.03%Kazakhmys (KAZ) 560.50p +0.99%Schroders (SDR) 2,056.00p +0.98%FTSE 100 - FallersAviva (AV.) 310.80p -13.62%Melrose Industries (MRO) 260.10p -2.62%Polymetal International (POLY) 958.00p -1.79%British Sky Broadcasting Group (BSY) 874.00p -1.63%Morrison (Wm) Supermarkets (MRW) 259.20p -1.52%Lloyds Banking Group (LLOY) 50.30p -1.41%Serco Group (SRP) 621.50p -0.88%Vodafone Group (VOD) 178.60p -0.78%Legal & General Group (LGEN) 164.90p -0.66%Old Mutual (OML) 208.80p -0.62%FTSE 250 - RisersRegus (RGU) 149.50p +4.18%Spirax-Sarco Engineering (SPX) 2,578.00p +3.00%RIT Capital Partners (RCP) 1,202.00p +2.56%SEGRO (SGRO) 264.60p +2.44%Cobham (COB) 234.20p +2.18%Betfair Group (BET) 702.00p +2.03%Jupiter Fund Management (JUP) 344.60p +1.83%Ashtead Group (AHT) 585.00p +1.74%Rotork (ROR) 2,951.00p +1.58%SIG (SHI) 142.50p +1.50%FTSE 250 - FallersNational Express Group (NEX) 206.90p -10.04%Petropavlovsk (POG) 257.10p -6.34%Hunting (HTG) 889.50p -4.51%Inmarsat (ISAT) 636.50p -4.36%IP Group (IPO) 135.00p -3.23%Balfour Beatty (BBY) 279.30p -2.68%Heritage Oil (HOIL) 192.50p -2.19%International Personal Finance (IPF) 463.90p -2.01%African Barrick Gold (ABG) 241.10p -1.87%Rank Group (RNK) 163.00p -1.69%BC
More News
12 Feb 2024 08:35

TOP NEWS: GSK's bepirovirsen receives US FDA fast track designation

(Alliance News) - GSK PLC on Monday said that the US health watchdog granted fast track designation for its bepirovirsen treatment for chronic hepatitis B.

Read more
12 Feb 2024 07:50

LONDON BRIEFING: Tritax Big Box, UK Commercial Property agree merger

(Alliance News) - Equities in London are called to open higher on Monday, with inflation readings from the US and UK on the horizon, which could drive equity market sentiment during the remainder of the week.

Read more
12 Feb 2024 07:21

GSK gets FDA fast track for chronic hepatitis B treatment

(Sharecast News) - GSK announced on Monday that bepirovirsen, an investigational antisense oligonucleotide (ASO) aimed at treating chronic hepatitis B (CHB), had been granted fast track designation by the US Food and Drug Administration (FDA).

Read more
9 Feb 2024 09:15

LONDON BROKER RATINGS: Deutsche Bank cuts AstraZeneca to 'sell'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
6 Feb 2024 08:51

TOP NEWS: GSK reports positive news on trio of high profile products

(Alliance News) - GSK PLC on Tuesday delivered a triple dose of positive updates on some of its leading products, Arexvy, Shingrix and Blencep.

Read more
6 Feb 2024 07:47

LONDON BRIEFING: BP promises buyback despite drop in profit

(Alliance News) - Stocks in London are called to open higher, ahead of a slew of construction purchasing managers' index readings from the eurozone, the UK and Germany.

Read more
6 Feb 2024 07:23

GSK reports positive myeloma trial results, progresses vaccine applications

(Sharecast News) - GSK reported progress in its trial of a myeloma treatment on Tuesday, as well as regulatory progress around its shingles vaccine in China and its RSV vaccine in the United States.

Read more
1 Feb 2024 09:27

TOP NEWS: GSK maintains "vigorous" defence after settling Zantac case

(Alliance News) - GSK PLC on Thursday insisted upon its scientific integrity, after reaching another settlement in ongoing litigation over alleged links between its heartburn drug and cancer.

Read more
1 Feb 2024 09:11

GSK settles Zantac case in California without admitting liability

(Sharecast News) - GSK announced on Thursday that it had reached a confidential settlement to effectively resolve the legal case over Zantac filed in a California state court.

Read more
1 Feb 2024 09:03

LONDON BROKER RATINGS: Barclays cuts Next; JPMorgan raises easyJet

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
1 Feb 2024 07:42

LONDON BRIEFING: Shell profit falls; announces USD3.5 billion buyback

(Alliance News) - Stocks in London are set to follow New York into the red, after the US Federal Reserve quashed hopes of a March cut to interest rates and ahead of the Bank of England interest rate decision.

Read more
31 Jan 2024 17:05

LONDON MARKET CLOSE: Stocks mixed hours before expected US Fed hold

(Alliance News) - Stock prices in London closed mixed on Wednesday in a trade-thinned day ahead of the US Federal Reserve interest rate decision this evening.

Read more
31 Jan 2024 15:49

London close: Stocks mixed ahead of US Fed, BoE decisions

(Sharecast News) - London's financial markets finished with mixed performance on Wednesday, with investors closing their wallets ahead of rate announcements from both the US Federal Reserve and the Bank of England.

Read more
31 Jan 2024 12:05

LONDON MARKET MIDDAY: FTSE 100 flat ahead of Federal Reserve decision

(Alliance News) - The FTSE 100 in London was flat heading into Wednesday afternoon, as the US Federal Reserve's latest interest rate decision edges closer, keeping equity market enthusiasm to a minimum.

Read more
31 Jan 2024 09:13

TOP NEWS: GSK profit up on Arexvy boost in 2023 but total payout down

(Alliance News) - GSK PLC reported an increase in profit and revenue for 2023 as revenue for HIV medicine had stable growth, amid optimism in the company's outlook.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.